Drug Trial Radar · NCT07052942
Individualizing Treatment for Asthma in Primary Care (Full Study)
Last checked: Nov 19, 2026Latest source record: Oct 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,200
Planned (sponsor's estimate)
Start
Aug 1, 2025
Primary completion
Nov 15, 2029
Study completion Nov 15, 2029
Sponsor
- Lead sponsor
- DARTNet InstituteGovernment (non-federal)
- Sponsor type
- Government (non-federal)
- Collaborators
- Penn State University; Icahn School of Medicine at Mount Sinai; University of Colorado, Denver; RAND; University of Washington; University of North Carolina; Reliant Medical Group; Kelsey Research Foundation; University of Kansas; University of Missouri-Columbia; John Peter Smith Health Network; Rutgers University; AdventHealth; Wake Forest University Health Sciences
- First posted
- Jul 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 13 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.
Conditions
- Asthma
- Asthma Attack
- Asthma Exacerbations
Interventions
Inhaled corticosteroid (ICS)Drug
Participants will use either a combination of budesonide/formoterol or mometasone/formoterol as both controller and rescue therapy or a stand alone inhaled steroid (beclomethasone, budesonide, fluticasone, mometasone, ciclesodine) of their choice with their current reliever therapy or be converted to budesonide/albuterol as rescue therapy.
AzithromycinDrug
Participants will take 500mg of azithromycin three times a week or 10mg/kg if under 50Kg which may be reduced to 250mg/Kg for side effects.
Asthma Symptom Monitoring Web-based ApplicationOther
All participants will be provided access to the Asthma Symptom Monitoring (ASM) tools. ASM can be integrated with electronic health records (EHR) or used as a stand alone application. Participants will answer 5 questions about their asthma each week. If symptoms are problematic, participants can request a call back from a person on their care team. Participants can view a graph of their data, watch videos, and record peak flows. Clinicians and members of the care team can view data in the EHR (not for stand alone web app).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Asthma Exacerbations Per YearTime frame: Follow-up is up to 16 months.
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
DARTNet Institute
Aurora, Colorado · Recruiting
University Colorado-Denver
Aurora, Colorado · Recruiting
AdventHealth
Orlando, Florida · Not yet recruiting
University of Kansas
Kansas City, Kansas · Not yet recruiting
Reliant Medical Group
Worcester, Massachusetts · Recruiting
University of Missouri
Columbia, Missouri · Not yet recruiting
Rutgers Robert Wood Johnson Medical School
New Brunswick, New Jersey · Recruiting
Mt. Sinai School of Medicine
New York, New York · Recruiting
University North Carolina
Chapel Hill, North Carolina · Recruiting
Atrium Health
Charlotte, North Carolina · Recruiting
JPS Health Network
Fort Worth, Texas · Not yet recruiting
Kelsey Research Foundation
Houston, Texas · Recruiting
University of Washington
Seattle, Washington · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.